 | • レポートコード：D0GIR-00901 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、注射型標的療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。注射型標的療法の種類別市場規模（モノクローナル抗体、小分子、免疫毒素、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、AstraZeneca、Bayer、Sanofi、AbbiVie、GSK、Roche、Merck、Amgen、Teva、Pfizer ・地域別グローバル市場分析 2015年-2020年 ・注射型標的療法の北米市場（アメリカ、カナダ、メキシコ） ・注射型標的療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・注射型標的療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・注射型標的療法の南米市場（ブラジル、アルゼンチン） ・注射型標的療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：モノクローナル抗体、小分子、免疫毒素、その他 ・用途別分析：病院、在宅医療、専門クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Injectable Targeted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Injectable Targeted Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Injectable Targeted Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Injectable Targeted Therapy market has been segmented into:
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others
By Application, Injectable Targeted Therapy has been segmented into:
Hospitals
Homecare
Specialty Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Injectable Targeted Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Injectable Targeted Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Injectable Targeted Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Injectable Targeted Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Injectable Targeted Therapy Market Share Analysis
Injectable Targeted Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Injectable Targeted Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Injectable Targeted Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Injectable Targeted Therapy are:
Novartis
AstraZeneca
Bayer
Sanofi
AbbiVie
GSK
Roche
Merck
Amgen
Teva
Pfizer
Among other players domestic and global, Injectable Targeted Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Injectable Targeted Therapy Market Overview
1.1 Product Overview and Scope of Injectable Targeted Therapy
1.2 Classification of Injectable Targeted Therapy by Type
1.2.1 Global Injectable Targeted Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Injectable Targeted Therapy Revenue Market Share by Type in 2019
1.2.3 Monoclonal Antibodies
1.2.4 Small-Molecules
1.2.5 Immunotoxins
1.2.6 Others
1.3 Global Injectable Targeted Therapy Market by Application
1.3.1 Overview: Global Injectable Targeted Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Injectable Targeted Therapy Market by Regions
1.4.1 Global Injectable Targeted Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Injectable Targeted Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Injectable Targeted Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Injectable Targeted Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Injectable Targeted Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Injectable Targeted Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Injectable Targeted Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbiVie
2.5.1 AbbiVie Details
2.5.2 AbbiVie Major Business
2.5.3 AbbiVie SWOT Analysis
2.5.4 AbbiVie Product and Services
2.5.5 AbbiVie Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Product and Services
2.6.4 GSK Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Product and Services
2.7.4 Roche Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Product and Services
2.8.4 Merck Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Product and Services
2.9.4 Amgen Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva
2.10.1 Teva Details
2.10.2 Teva Major Business
2.10.3 Teva Product and Services
2.10.4 Teva Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Product and Services
2.11.4 Pfizer Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Injectable Targeted Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Injectable Targeted Therapy Players Market Share
3.2.2 Top 10 Injectable Targeted Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Injectable Targeted Therapy Revenue and Market Share by Regions
4.2 North America Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
5 North America Injectable Targeted Therapy Revenue by Countries
5.1 North America Injectable Targeted Therapy Revenue by Countries (2015-2020)
5.2 USA Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
6 Europe Injectable Targeted Therapy Revenue by Countries
6.1 Europe Injectable Targeted Therapy Revenue by Countries (2015-2020)
6.2 Germany Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
6.4 France Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Injectable Targeted Therapy Revenue by Countries
7.1 Asia-Pacific Injectable Targeted Therapy Revenue by Countries (2015-2020)
7.2 China Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
7.5 India Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
8 South America Injectable Targeted Therapy Revenue by Countries
8.1 South America Injectable Targeted Therapy Revenue by Countries (2015-2020)
8.2 Brazil Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Injectable Targeted Therapy by Countries
9.1 Middle East & Africa Injectable Targeted Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Injectable Targeted Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Injectable Targeted Therapy Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2015-2025)
10.4 Small-Molecules Revenue Growth Rate (2015-2025)
10.5 Immunotoxins Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Injectable Targeted Therapy Market Segment by Application
11.1 Global Injectable Targeted Therapy Revenue Market Share by Application (2015-2020)
11.2 Injectable Targeted Therapy Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Homecare Revenue Growth (2015-2020)
11.5 Specialty Clinics Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Injectable Targeted Therapy Market Size Forecast (2021-2025)
12.1 Global Injectable Targeted Therapy Market Size Forecast (2021-2025)
12.2 Global Injectable Targeted Therapy Market Forecast by Regions (2021-2025)
12.3 North America Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
12.6 South America Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Injectable Targeted Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Injectable Targeted Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Injectable Targeted Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Injectable Targeted Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Injectable Targeted Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Novartis Corporate Information, Location and Competitors
Table 7. Novartis Injectable Targeted Therapy Major Business
Table 8. Novartis Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Novartis SWOT Analysis
Table 10. Novartis Injectable Targeted Therapy Product and Solutions
Table 11. Novartis Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. AstraZeneca Corporate Information, Location and Competitors
Table 13. AstraZeneca Injectable Targeted Therapy Major Business
Table 14. AstraZeneca Injectable Targeted Therapy Total Revenue (USD Million) (2018-2019)
Table 15. AstraZeneca SWOT Analysis
Table 16. AstraZeneca Injectable Targeted Therapy Product and Solutions
Table 17. AstraZeneca Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Bayer Corporate Information, Location and Competitors
Table 19. Bayer Injectable Targeted Therapy Major Business
Table 20. Bayer Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 21. Bayer SWOT Analysis
Table 22. Bayer Injectable Targeted Therapy Product and Solutions
Table 23. Bayer Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Sanofi Corporate Information, Location and Competitors
Table 25. Sanofi Injectable Targeted Therapy Major Business
Table 26. Sanofi Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Sanofi SWOT Analysis
Table 28. Sanofi Injectable Targeted Therapy Product and Solutions
Table 29. Sanofi Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AbbiVie Corporate Information, Location and Competitors
Table 31. AbbiVie Injectable Targeted Therapy Major Business
Table 32. AbbiVie Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 33. AbbiVie SWOT Analysis
Table 34. AbbiVie Injectable Targeted Therapy Product and Solutions
Table 35. AbbiVie Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. GSK Corporate Information, Location and Competitors
Table 37. GSK Injectable Targeted Therapy Major Business
Table 38. GSK Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 39. GSK SWOT Analysis
Table 40. GSK Injectable Targeted Therapy Product and Solutions
Table 41. GSK Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Roche Corporate Information, Location and Competitors
Table 43. Roche Injectable Targeted Therapy Major Business
Table 44. Roche Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Roche SWOT Analysis
Table 46. Roche Injectable Targeted Therapy Product and Solutions
Table 47. Roche Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Merck Corporate Information, Location and Competitors
Table 49. Merck Injectable Targeted Therapy Major Business
Table 50. Merck Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Merck SWOT Analysis
Table 52. Merck Injectable Targeted Therapy Product and Solutions
Table 53. Merck Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Amgen Corporate Information, Location and Competitors
Table 55. Amgen Injectable Targeted Therapy Major Business
Table 56. Amgen Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Amgen SWOT Analysis
Table 58. Amgen Injectable Targeted Therapy Product and Solutions
Table 59. Amgen Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Teva Corporate Information, Location and Competitors
Table 61. Teva Injectable Targeted Therapy Major Business
Table 62. Teva Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 63. Teva SWOT Analysis
Table 64. Teva Injectable Targeted Therapy Product and Solutions
Table 65. Teva Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Pfizer Corporate Information, Location and Competitors
Table 67. Pfizer Injectable Targeted Therapy Major Business
Table 68. Pfizer Injectable Targeted Therapy Total Revenue (USD Million) (2017-2018)
Table 69. Pfizer SWOT Analysis
Table 70. Pfizer Injectable Targeted Therapy Product and Solutions
Table 71. Pfizer Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global Injectable Targeted Therapy Revenue (Million USD) by Players (2015-2020)
Table 73. Global Injectable Targeted Therapy Revenue Share by Players (2015-2020)
Table 74. Global Injectable Targeted Therapy Revenue (Million USD) by Regions (2015-2020)
Table 75. Global Injectable Targeted Therapy Revenue Market Share by Regions (2015-2020)
Table 76. North America Injectable Targeted Therapy Revenue by Countries (2015-2020)
Table 77. North America Injectable Targeted Therapy Revenue Market Share by Countries (2015-2020)
Table 78. Europe Injectable Targeted Therapy Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific Injectable Targeted Therapy Revenue (Million USD) by Countries (2015-2020)
Table 80. South America Injectable Targeted Therapy Revenue by Countries (2015-2020)
Table 81. South America Injectable Targeted Therapy Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa Injectable Targeted Therapy Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa Injectable Targeted Therapy Revenue Market Share by Countries (2015-2020)
Table 84. Global Injectable Targeted Therapy Revenue (Million USD) by Type (2015-2020)
Table 85. Global Injectable Targeted Therapy Revenue Share by Type (2015-2020)
Table 86. Global Injectable Targeted Therapy Revenue Forecast by Type (2021-2025)
Table 87. Global Injectable Targeted Therapy Revenue by Application (2015-2020)
Table 88. Global Injectable Targeted Therapy Revenue Share by Application (2015-2020)
Table 89. Global Injectable Targeted Therapy Revenue Forecast by Application (2021-2025)
Table 90. Global Injectable Targeted Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Injectable Targeted Therapy Picture
Figure 2. Global Injectable Targeted Therapy Revenue Market Share by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Small-Molecules Picture
Figure 5. Immunotoxins Picture
Figure 6. Others Picture
Figure 7. Injectable Targeted Therapy Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Homecare Picture
Figure 10. Specialty Clinics Picture
Figure 11. Others Picture
Figure 12. Global Injectable Targeted Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Injectable Targeted Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Injectable Targeted Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Injectable Targeted Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Injectable Targeted Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Injectable Targeted Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Injectable Targeted Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Injectable Targeted Therapy Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Injectable Targeted Therapy Revenue Market Share in 2019
Figure 21. Global Top 10 Players Injectable Targeted Therapy Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Injectable Targeted Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Injectable Targeted Therapy Revenue Market Share by Regions (2015-2020)
Figure 25. Global Injectable Targeted Therapy Revenue Market Share by Regions in 2018
Figure 26. North America Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Europe Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 29. South America Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 31. North America Injectable Targeted Therapy Revenue Market Share by Countries (2015-2020)
Figure 32. North America Injectable Targeted Therapy Revenue Market Share by Countries in 2019
Figure 33. USA Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Canada Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 36. Europe Injectable Targeted Therapy Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Injectable Targeted Therapy Revenue Market Share by Countries in 2019
Figure 38. Germany Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 39. UK Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 40. France Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Russia Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 42. Italy Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Injectable Targeted Therapy Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Injectable Targeted Therapy Revenue Market Share by Countries in 2019
Figure 45. China Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Japan Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Korea Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 48. India Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 50. South America Injectable Targeted Therapy Revenue Market Share by Countries (2015-2020)
Figure 51. South America Injectable Targeted Therapy Revenue Market Share by Countries in 2019
Figure 52. Brazil Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Injectable Targeted Therapy Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Injectable Targeted Therapy Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 57. UAE Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Injectable Targeted Therapy Revenue and Growth Rate (2015-2020)
Figure 60. Global Injectable Targeted Therapy Revenue Share by Type (2015-2020)
Figure 61. Global Injectable Targeted Therapy Revenue Share by Type in 2019
Figure 62. Global Injectable Targeted Therapy Market Share Forecast by Type (2021-2025)
Figure 63. Global Monoclonal Antibodies Revenue Growth Rate (2015-2020)
Figure 64. Global Small-Molecules Revenue Growth Rate (2015-2020)
Figure 65. Global Immunotoxins Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Injectable Targeted Therapy Revenue Share by Application (2015-2020)
Figure 68. Global Injectable Targeted Therapy Revenue Share by Application in 2019
Figure 69. Global Injectable Targeted Therapy Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Homecare Revenue Growth Rate (2015-2020)
Figure 72. Global Specialty Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Injectable Targeted Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Injectable Targeted Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Injectable Targeted Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
Figure 78. Europe Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
Figure 80. South America Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Injectable Targeted Therapy Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
小分子標的治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Small Molecule Targeted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 糖尿病用注射薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Injectable Drugs For Diabetes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 2型糖尿病用注射薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Injectable Drugs For Type-2 Diabete market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- フェイシャルインジェクタブルの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Facial Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.0% in the forecast period of 2020 to 2025 and will expected to reach USD 9748.1 million by 2025, from USD 7711.6 million in 2019. The Facial Injectable …
- 注射型鎮痛薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Injectable Pain Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…